CSI Market
Sign In | Register

Avid Bioservices Inc (CDMO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CDMO Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Avid Bioservices Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Oct 31 2024)
6 Months 		(Jul 31 2024) (Apr 30 2024) (Jan 31 2024) (Oct 31 2023)
Operating Activities
Income-22.94
Depreciation & amortization6.80
Amortization of Other Assets0.59
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories2.30
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation6.13
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Share Based Goods And Nonemployee Services Transaction Cash Flow Effects-
Share Based Goods And Nonemployee Services Transaction Expense-
Property Plant And Equipment Disposals-
Increase Decrease In Government Contract Receivables-
Amortization Of Expenses Paid In Shares Of Common Stock-
Stock Issued During Period Value Issued For Services-
Increase Decrease In Contract Assets-
Increase Decrease In Assets Of Discontinued Operations-
Increase Decrease In Contract Liabilities-
Increase Decrease In Contract With Customer Asset0.56
Increase Decrease In Contract With Customer Liability11.78
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable1.02
Increase (Decrease) in Accounts Payable-9.37
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.15
Other Working Capital1.29
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities0.31
Investing Activities
Capital Expenditures-4.76
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-4.76
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.97
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.73
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment Of Final Fee On Notes Payable-
Finance Lease Principal Payments-
Purchases Of Capped Calls Related To Convertible Senior Notes-
Impact Of Preferred Stock Redemption-
Proceeds From Finance Lease-
Proceeds From Unwinding Of Capped Calls-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.25
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.44
Total Cash Flow-4.69
4 historic quarters locked

Sign in to unlock the full Avid Bioservices Inc cash flow history.

Sign In Create Free Account

About Avid Bioservices Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001683168-24-008620

Figures are derived from filed reports and may be restated. Historical data is subject to revision.